Elimination of hepatitis C virus infection from a hemodialysis unit and impact of treatment on the control of anemia. [electronic resource]
Producer: 20191118Description: 164-170 p. digitalISSN:- 0210-5705
- 2-Naphthylamine
- Anemia -- drug therapy
- Anilides
- Antiviral Agents -- therapeutic use
- Carbamates
- Cyclopropanes
- Darbepoetin alfa -- administration & dosage
- Female
- Hematinics -- administration & dosage
- Hematocrit
- Hemoglobin A
- Hepatitis C -- drug therapy
- Humans
- Lactams, Macrocyclic
- Macrocyclic Compounds -- therapeutic use
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Prospective Studies
- Renal Dialysis
- Renal Insufficiency, Chronic -- complications
- Ritonavir -- therapeutic use
- Sulfonamides -- therapeutic use
- Sustained Virologic Response
- Uracil -- analogs & derivatives
- Valine
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.